Skip to content

Weekly medical newspersonalized for your condition

Every email is made specifically for your health condition. We curate the latest medical papers, treatment advances, clinical trials that are actually relevant to you.

Personalized health news, delivered once a week to your inbox.

We will email you a confirmation and deliver your weekly brief.

By subscribing, you acknowledge this newsletter is for information only and not a substitute for professional medical advice, diagnosis or treatment. You consent to receive emails from us and agree to our terms and privacy practices. This applies to our AI assistant for research papers as well.

Weekly • Free • No spam, unsubscribe anytime


Magic Giraffe delivering your weekly brief
📰This week on PubMed
  • •GLP‑1 therapies and cardiovascular outcomes in Type 2 Diabetes — systematic review
  • •Long‑acting bronchodilators in COPD: real‑world exacerbation reduction study
🧪New clinical trials for Rheumatoid Arthritis
JAK inhibitor vs. Methotrexate — flare preventionRecruiting
Biologic tapering strategy in sustained remissionEnrolling

Curated summaries • Chronic condition focus • Private by design

Researcher or PhD?

Just replace arxiv.org or medrxiv.org with giraffeguru.com to use our AI assistant to understand research papers.

Examples:

GLP-1 RA Prescribing Trends

medrxiv.org/content/10.1101/2024.01.18.24301500v4

giraffeguru.com/content/10.1101/2024.01.18.24301500v4

Cosmological Constraints on Secluded Dark Radiation

arxiv.org/pdf/2510.01309

giraffeguru.com/pdf/2510.01309

Stay ahead with a 3‑minute weekly brief

We scan PubMed and ClinicalTrials.gov and send you the most relevant updates for your condition.

1

Tell us your condition

Focus on chronic illnesses like Diabetes, COPD, RA, CKD, MS

2

Get a weekly digest

Clear summaries of new studies and trials — right in your inbox

3

Explore what’s relevant

Dive deeper when something looks promising for you and your care

11,000,000+
Journals Scanned
553,000+
Trials Tracked
870+
Health Conditions Monitored
Weekly
Delivered Every Friday